patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug
EPYSQLI
Marketedupdated 2mo agoby Samsung Bioepis Co Ltd
Approvedcommunity read0 votes
all catalysts(10)
approval · 10
Jul 19, 2024
approval
EPYSQLI (ECULIZUMAB-AAGH) — FDA approval
EPYSQLI
→
Nov 15, 2024
approval
EPYSQLI (ECULIZUMAB-AAGH) — FDA approval
EPYSQLI
→
Jan 21, 2025
approval
EPYSQLI (ECULIZUMAB-AAGH) — FDA approval
EPYSQLI
→
Jan 28, 2025
approval
EPYSQLI (ECULIZUMAB-AAGH) — FDA approval
EPYSQLI
→
Mar 12, 2025
approval
EPYSQLI (ECULIZUMAB-AAGH) — FDA approval
EPYSQLI
→
Apr 30, 2025
approval
EPYSQLI (ECULIZUMAB-AAGH) — FDA approval
EPYSQLI
→
Sep 2, 2025
approval
EPYSQLI (ECULIZUMAB-AAGH) — FDA approval
EPYSQLI
→
Nov 10, 2025
approval
EPYSQLI (ECULIZUMAB-AAGH) — FDA approval
EPYSQLI
→
Nov 28, 2025
approval
EPYSQLI (ECULIZUMAB-AAGH) — FDA approval
EPYSQLI
→
Jan 23, 2026
approval
EPYSQLI (ECULIZUMAB-AAGH) — FDA approval
EPYSQLI
→
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that